BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8218851)

  • 1. Plasma kallikrein and thrombin are cleared through unrelated hepatic pathways.
    Loureiro-Silva MR; Kouyoumdjian M; Borges DR
    Blood Coagul Fibrinolysis; 1993 Aug; 4(4):551-4. PubMed ID: 8218851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor-mediated clearance of tissue kallikreins by rat liver.
    Borges DR; Kouyoumdjian M; Prado ES; Prado JL
    Adv Exp Med Biol; 1986; 198 Pt A():235-9. PubMed ID: 3643709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma-kallikrein clearance by the liver of acetaminophen-intoxicated rats.
    de Toledo CF; Borges DR
    Life Sci; 1993; 52(17):1451-9. PubMed ID: 8464345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hepatic clearance of recombinant tissue-type plasminogen activator decreases after an inflammatory stimulus.
    Nagaoka MR; Kouyoumdjian M; Borges DR
    Braz J Med Biol Res; 2000 Jan; 33(1):119-25. PubMed ID: 10625883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Native plasma kallikrein is cleared at similar rates by mammalian and avian livers.
    Borges DR; Kouyoumdjian M; Limãos EA
    Braz J Med Biol Res; 1991; 24(1):63-5. PubMed ID: 1823219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The recognition site for hepatic clearance of plasma kallikrein is on its heavy chain and is latent on prokallikrein.
    Borges DR; Kouyoumdjian M
    J Hepatol; 1992 Sep; 16(1-2):115-21. PubMed ID: 1484145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Plasma kallikrein clearance by the liver in experimental cirrhosis].
    de Toledo CF; Loureiro-Silva MR; Molina HM; Lanzoni VP; Kouyoumdjian M; Borges DR
    Rev Assoc Med Bras (1992); 1995; 41(6):367-72. PubMed ID: 8733244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chloramine T impairs the receptor-mediated endocytosis of plasma kallikrein by the liver.
    Borges DR; Kouyoumdjian M
    Agents Actions Suppl; 1992; 38 ( Pt 2)():278-84. PubMed ID: 1462833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of cluster galactosides with high affinity for the hepatic asialoglycoprotein receptor.
    Biessen EA; Beuting DM; Roelen HC; van de Marel GA; van Boom JH; van Berkel TJ
    J Med Chem; 1995 Apr; 38(9):1538-46. PubMed ID: 7739012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigating clearance mechanisms for recombinant activated factor VII in a perfused liver model.
    Appa R; Theill C; Hansen L; Møss J; Behrens C; Nicolaisen EM; Klausen NK; Christensen MS
    Thromb Haemost; 2010 Aug; 104(2):243-51. PubMed ID: 20508904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between clearance rates of plasma kallikrein and of plasma kallikrein-alpha-macroglobulin complexes by the liver.
    Ogata H; Kouyoumdjian M; Borges DR
    Int J Biochem; 1993 Jul; 25(7):1047-51. PubMed ID: 7689988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesterol derivative of a new triantennary cluster galactoside lowers serum cholesterol levels and enhances secretion of bile acids in the rat.
    Biessen EA; Vietsch H; Van Berkel TJ
    Circulation; 1995 Mar; 91(6):1847-54. PubMed ID: 7882496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma kallikrein clearance by the liver of chronic carbon tetrachloride-treated rats.
    Toledo CF; Kouyoumdjian M; Lanzoni VP; Borges DR
    J Gastroenterol Hepatol; 1995; 10(2):165-8. PubMed ID: 7787162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decrease in the hepatic clearance of hepatocyte growth factor in carbon tetrachloride-intoxicated rats.
    Liu KX; Kato Y; Yamazaki M; Higuchi O; Nakamura T; Sugiyama Y
    Hepatology; 1993 Apr; 17(4):651-60. PubMed ID: 8477970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of an asialoglycoprotein receptor-targeted magnetic resonance contrast agent to study changes in receptor biology during liver regeneration and endotoxemia in rats.
    Leveille-Webster CR; Rogers J; Arias IM
    Hepatology; 1996 Jun; 23(6):1631-41. PubMed ID: 8675187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cholesterol derivative of a triantennary galactoside with high affinity for hepatic asialoglycoprotein receptor: a potent cholesterol lowering agent.
    Biessen EA; Broxterman H; van Boom JH; van Berkel TJ
    J Med Chem; 1995 May; 38(11):1846-52. PubMed ID: 7783116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clearance of thrombin from circulation in rabbits by high-affinity binding sites on endothelium. Possible role in the inactivation of thrombin by antithrombin III.
    Lollar P; Owen WG
    J Clin Invest; 1980 Dec; 66(6):1222-30. PubMed ID: 6255009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo catabolism of heparin cofactor II and its complex with thrombin: evidence for a common receptor-mediated clearance pathway for three serine proteinase inhibitors.
    Pratt CW; Church FC; Pizzo SV
    Arch Biochem Biophys; 1988 Apr; 262(1):111-7. PubMed ID: 3258496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and characterization of PK-120, a novel substrate for plasma kallikrein, from guinea pig plasma.
    Pu XP; Nagasawa S
    Biol Pharm Bull; 1995 Jun; 18(6):837-41. PubMed ID: 7550116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rat plasma kallikrein clearance by perfused rat liver.
    Borges DR; Gordon AH; Guimarães JA; Prado JL
    Braz J Med Biol Res; 1985; 18(2):187-94. PubMed ID: 3006849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.